Adaptimmune
Adaptimmune is a leader in T-cell cancer therapy. Dr Jo Brewer is the VP of Platform Sciences Research.
Date:
24 October 2018, 18:00 (Wednesday, 3rd week, Michaelmas 2018)
Venue:
Dorothy Crowfoot Hodgkin Building, off South Parks Road OX1 3QU
Venue Details:
Main seminar room (located on the ground floor and has step-free access)
Speakers:
Speaker to be announced
Organiser contact email address:
info@oxfordbiotech.uk
Booking required?:
Not required
Audience:
Public
Editors:
Noah Sprent,
Zhanna Kryukova
